Meridian Bioscience
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Meridian Bioscience generated cash of $82,361,000, which is more than the previous year. Cash used in financing activities reached the amount of -$34,303,000 last year. Net change in cash is therefore $31,682,000.
Cash Flow
| 2014 | 38.26M | -7.00M | -31.75M |
|---|---|---|---|
| 2015 | 42.80M | -3.62M | -30.74M |
| 2016 | 37.22M | -66.69M | 27.20M |
| 2017 | 41.35M | -4.46M | -27.71M |
| 2018 | 34.78M | -4.20M | -27.59M |
| 2019 | 35.83M | -48.45M | 15.26M |
| 2020 | 47.97M | -54.59M | -3.55M |
| 2021 | 66.86M | -40.39M | -31.06M |
| 2022 | 82.36M | -11.11M | -34.30M |
0K0K.L Cash Flow Statement (2014 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 49.77M | 53.51M | 62.39M | 60.76M | 57.07M | 47.22M | 49.97M | 43.04M | 44.28M |
Operating activities | |||||||||
Net income | 42.45M | 71.40M | 46.18M | 24.38M | 23.84M | 21.55M | 32.22M | 35.54M | 34.74M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 16.51M | 15.28M | 13.56M | 9.96M | 7.92M | 8.11M | 6.62M | 5.21M | 5.56M |
Stock-based compensation expense | 6.9M | 4.15M | 3.80M | 3.25M | 3.40M | 3.38M | 2.91M | 3.32M | 3.55M |
| Deferred income tax benefit | 6.9M | 4.15M | 3.80M | 3.25M | 3.40M | 3.38M | 2.91M | 3.32M | 3.55M |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 4.56M | -12.76M | -971K | -2.31M | -4.44M | 0 | 0 | 0 | 0 |
Inventories | 5.22M | -7.8M | -18.97M | 3.84M | -1.14M | 0 | 0 | 0 | 0 |
Accounts payable | 1.03M | 6.34M | 7.24M | -2.31M | 4.12M | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 82.36M | 66.86M | 47.97M | 35.83M | 34.78M | 41.35M | 37.22M | 42.80M | 38.26M |
Investing activities | |||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | -600K | 0 | 0 |
Investments In Property Plant And Equipment | -8.61M | -18.31M | -3.29M | -3.79M | -4.20M | -4.46M | -4.00M | -4.76M | -7.00M |
Acquisitions Net | -3.75M | -23.58M | -51.29M | -45.32M | 0 | 0 | -62.09M | 0 | 0 |
Cash generated by investing activities | -11.11M | -40.39M | -54.59M | -48.45M | -4.20M | -4.46M | -66.69M | -3.62M | -7.00M |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | -10.61M | -21.17M | -24.26M | -33.64M | -33.35M | -32.76M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -18.82M | -57M | 0 | -4.5M | 0 | -1.5M | 0 | 0 |
Cash used in financing activities | -34.30M | -31.06M | -3.55M | 15.26M | -27.59M | -27.71M | 27.20M | -30.74M | -31.75M |
Net Change In Cash | 31.68M | -3.74M | -8.88M | 1.63M | 2.69M | 9.84M | -2.74M | 6.92M | -1.23M |
Cash at end of period | 81.45M | 49.77M | 53.51M | 62.39M | 59.76M | 57.07M | 47.22M | 49.97M | 43.04M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |